This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Ranked Growth Stocks to Buy for July 13th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 13th
The Zacks Analyst Blog Highlights: Apple, Microsoft, TMobile US, Goldman Sachs and Cigna
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Microsoft, TMobile US, Goldman Sachs and Cigna
Here's Why You Should Add Old Republic (ORI) to Your Portfolio
by Zacks Equity Research
Old Republic (ORI) is poised for growth given its strong market position, segmental growth and efficient usage of capital.
Top Research Reports for Apple, Microsoft & TMobile
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Microsoft (MSFT) and TMobile US (TMUS).
Top Ranked Growth Stocks to Buy for July 8th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 8th
5 Reasons That Make Cigna (CI) an Attractive Stock to Own
by Zacks Equity Research
Acquisitions, business streamlining, strong balance sheet, high profitability, clear visibility of earnings growth make Cigna (CI) and attractive bet.
Top Ranked Growth Stocks to Buy for July 6th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 6th
Why Cigna (CI) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Cigna (CI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Teladoc (TDOC) Scales 52 Week High on InTouch Health Purchase
by Zacks Equity Research
Teladoc (TDOC) shares touch a 52-week high following the news of InTouch Health acquisition.
Here's Why Hold Strategy is Appropriate for MGIC Investment
by Zacks Equity Research
MGIC Investment (MTG) is poised to grow given its improved premium, solid new business written and strong persistency, partly offset by high cost.
Here's Why Hold Strategy is Apt for Kemper (KMPR) Stock Now
by Zacks Equity Research
Kemper Corporation (KMPR) is poised for growth, given a compelling product portfolio and solid capital position.
Teladoc (TDOC) Acquires InTouch Health, Boosts Virtual Care
by Zacks Equity Research
Teladoc (TDOC) intends to offer enhanced virtual care services for clients with InTouch Health buyout.
Can Value Investors Pick Cigna Corporation (CI) Stock Now?
by Zacks Equity Research
Is Cigna Corporation (CI) a great pick from the value investor's perspective right now? Read on to know more.
Is Cigna (CI) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Cigna (CI) could produce exceptional returns because of its solid growth attributes.
Are Investors Undervaluing Cigna (CI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna, Oscar to Launch Health Plan for Small Businesses
by Zacks Equity Research
Cigna (CI) along with Oscar unveils markets for Cigna + Oscar, aimed at aiding small businesses.
Cigna, Priority Health Team Up to Offer Improved Healthcare
by Zacks Equity Research
Cigna's (CI) collaboration with Priority Health intends to provide improved health outcomes for the Michigan community and out-of-state members of Priority Health.
Cigna's Tie-Up to Offer Improved Healthcare in North Alabama
by Zacks Equity Research
Cigna's (CI) alliance with Huntsville Hospital intends to provide improved health outcomes for the company's members under its Medicare Advantage plans.
Telehealth Poised for Long-Term Growth Post Coronavirus
by Zacks Equity Research
Telehealth is here to stay for the long haul, given the changes prompted by COVID-19.
Molina Healthcare (MOH) Continues to Waive Coronavirus Expenses
by Zacks Equity Research
Molina Healthcare (MOH) continues to reduce "out-of-pocket" expenses related to coronavirus treatment for its members and undertakes several other initiatives.
Why Is Cigna (CI) Up 0.8% Since Last Earnings Report?
by Zacks Equity Research
Cigna (CI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna's (CI) Earnings View Reaffirmation Reflects Solid Business Profile
by Sapna Bagaria
Cigna's (CI) retention of current-year guidance underlines its ability to tide over the present bleak business and economic landscape created by COVID-19.
Cigna Adds Capabilities to Expand Its Virtual Care Service
by Zacks Equity Research
Cigna (CI) has added a private messaging application to better serve its members amid COVID-19 breakout.
Cigna (CI) Dispenses Digital Services to Fight Coronavirus
by Zacks.com
Cigna (CI) offers digital solutions to facilitate real-time support to its customers for tracking coronavirus symptoms.
Cigna (CI) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cigna (CI) delivered earnings and revenue surprises of 5.63% and 3.09%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?